Company intelligence / Profile preview

Ambee Pharmaceuticals

Dhaka, Bangladesh

Ownership: Private
Employees: ~529
Development stage: Other

Overview

Ambee Pharmaceuticals manufactures and sells over 75 generic medicines in Bangladesh, including antibiotics, cardiovascular, anti-inflammatory, and vitamin/mineral products. The company is GMP and ISO 9001 certified and has joint ventures for product expansion. Export activities are limited but ongoing (notably to Myanmar). Clinical trial data is not published as the products are largely generics.

Therapeutic areas: ImmunologyEndocrinologyRheumatologyMetabolic DisordersPsychiatryInfectious DiseasesGastroenterologyHematologyPulmonologyCardiovascularOtherNeurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

STOMACID

Unknown

Partnerships

Medimpex (Hungary) (joint venture)

Beyond the preview

Go deeper on Ambee Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ambee Pharmaceuticals.

Explore the full profile